Dutta, R., Lunzer, M. M., Auger, J. L., Akgün, E., Portoghese, P. S., & Binstadt, B. A. (2018). A bivalent compound targeting CCR5 and the mu opioid receptor treats inflammatory arthritis pain in mice without inducing pharmacologic tolerance. Arthritis Res Ther.

Dutta, Raini, Mary M. Lunzer, Jennifer L. Auger, Eyup Akgün, Philip S. Portoghese, and Bryce A. Binstadt. "A Bivalent Compound Targeting CCR5 and the Mu Opioid Receptor Treats Inflammatory Arthritis Pain in Mice Without Inducing Pharmacologic Tolerance." Arthritis Res Ther 2018.

Dutta, Raini, et al. "A Bivalent Compound Targeting CCR5 and the Mu Opioid Receptor Treats Inflammatory Arthritis Pain in Mice Without Inducing Pharmacologic Tolerance." Arthritis Res Ther 2018.